255 related articles for article (PubMed ID: 22426112)
1. LYP inhibits T-cell activation when dissociated from CSK.
Vang T; Liu WH; Delacroix L; Wu S; Vasile S; Dahl R; Yang L; Musumeci L; Francis D; Landskron J; Tasken K; Tremblay ML; Lie BA; Page R; Mustelin T; Rahmouni S; Rickert RC; Tautz L
Nat Chem Biol; 2012 Mar; 8(5):437-46. PubMed ID: 22426112
[TBL] [Abstract][Full Text] [Related]
2. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling.
de la Puerta ML; Trinidad AG; Rodríguez Mdel C; de Pereda JM; Sánchez Crespo M; Bayón Y; Alonso A
PLoS One; 2013; 8(1):e54569. PubMed ID: 23359562
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue.
Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N
J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612
[TBL] [Abstract][Full Text] [Related]
4. Immunology: Csk keeps LYP on a leash.
Zhong MC; Veillette A
Nat Chem Biol; 2012 Apr; 8(5):412-3. PubMed ID: 22510660
[No Abstract] [Full Text] [Related]
5. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T cell receptor.
Vang T; Torgersen KM; Sundvold V; Saxena M; Levy FO; Skålhegg BS; Hansson V; Mustelin T; Taskén K
J Exp Med; 2001 Feb; 193(4):497-507. PubMed ID: 11181701
[TBL] [Abstract][Full Text] [Related]
6. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.
Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY
Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643
[TBL] [Abstract][Full Text] [Related]
7. TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22.
Wallis AM; Wallace EC; Hostager BS; Yi Z; Houtman JCD; Bishop GA
Sci Rep; 2017 May; 7(1):2081. PubMed ID: 28522807
[TBL] [Abstract][Full Text] [Related]
8. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase.
Cloutier JF; Veillette A
J Exp Med; 1999 Jan; 189(1):111-21. PubMed ID: 9874568
[TBL] [Abstract][Full Text] [Related]
9. Autoimmunity-associated LYP-W620 does not impair thymic negative selection of autoreactive T cells.
Wu DJ; Zhou W; Enouz S; Orrú V; Stanford SM; Maine CJ; Rapini N; Sawatzke K; Engel I; Fiorillo E; Sherman LA; Kronenberg M; Zehn D; Peterson E; Bottini N
PLoS One; 2014; 9(2):e86677. PubMed ID: 24498279
[TBL] [Abstract][Full Text] [Related]
10. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.
Brdicka T; Pavlistová D; Leo A; Bruyns E; Korínek V; Angelisová P; Scherer J; Shevchenko A; Hilgert I; Cerný J; Drbal K; Kuramitsu Y; Kornacker B; Horejsí V; Schraven B
J Exp Med; 2000 May; 191(9):1591-604. PubMed ID: 10790433
[TBL] [Abstract][Full Text] [Related]
11. Lymphoid-specific tyrosine phosphatase (Lyp): a potential drug target for treatment of autoimmune diseases.
Du J; Qiao Y; Sun L; Wang X
Curr Drug Targets; 2014 Mar; 15(3):335-46. PubMed ID: 24188455
[TBL] [Abstract][Full Text] [Related]
12. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling.
Vang T; Abrahamsen H; Myklebust S; Horejsí V; Taskén K
J Biol Chem; 2003 May; 278(20):17597-600. PubMed ID: 12665526
[TBL] [Abstract][Full Text] [Related]
13. PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling.
Yang S; Svensson MND; Harder NHO; Hsieh WC; Santelli E; Kiosses WB; Moresco JJ; Yates JR; King CC; Liu L; Stanford SM; Bottini N
Sci Signal; 2020 Mar; 13(623):. PubMed ID: 32184287
[TBL] [Abstract][Full Text] [Related]
14. Identification and structure-function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22.
Li K; Hou X; Li R; Bi W; Yang F; Chen X; Xiao P; Liu T; Lu T; Zhou Y; Tian Z; Shen Y; Zhang Y; Wang J; Fang H; Sun J; Yu X
J Biol Chem; 2019 May; 294(21):8653-8663. PubMed ID: 30979725
[TBL] [Abstract][Full Text] [Related]
15. TCR-induced downregulation of protein tyrosine phosphatase PEST augments secondary T cell responses.
Arimura Y; Vang T; Tautz L; Williams S; Mustelin T
Mol Immunol; 2008 Jun; 45(11):3074-84. PubMed ID: 18457880
[TBL] [Abstract][Full Text] [Related]
16. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation.
Manjarrez-Orduño N; Marasco E; Chung SA; Katz MS; Kiridly JF; Simpfendorfer KR; Freudenberg J; Ballard DH; Nashi E; Hopkins TJ; Cunninghame Graham DS; Lee AT; Coenen MJ; Franke B; Swinkels DW; Graham RR; Kimberly RP; Gaffney PM; Vyse TJ; Behrens TW; Criswell LA; Diamond B; Gregersen PK
Nat Genet; 2012 Nov; 44(11):1227-30. PubMed ID: 23042117
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway.
Park JE; Brand DD; Rosloniec EF; Yi AK; Stuart JM; Kang AH; Myers LK
J Biol Chem; 2020 Feb; 295(8):2239-2247. PubMed ID: 31932281
[TBL] [Abstract][Full Text] [Related]
18. Release from tonic inhibition of T cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts.
Torgersen KM; Vang T; Abrahamsen H; Yaqub S; Horejsí V; Schraven B; Rolstad B; Mustelin T; Taskén K
J Biol Chem; 2001 Aug; 276(31):29313-8. PubMed ID: 11390365
[TBL] [Abstract][Full Text] [Related]
19. The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors.
Davidson D; Zhong MC; Pandolfi PP; Bolland S; Xavier RJ; Seed B; Li X; Gu H; Veillette A
Cell Rep; 2016 Dec; 17(10):2776-2788. PubMed ID: 27926878
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of the
Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM
J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
